Weight loss: GLP-1 agonists may increase risk of stomach paralysis - Medical News Today
medicalnewstoday.comSubmitted by medicalnewstoday7131 in health
A new study has linked popular GLP-1 agonists for weight loss like Ozempic and Wegovy to stomach paralysis, pancreatitis, and gastrointestinal issues.